OCGN CIK: 1372299

Ocugen, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.9
FY22:
−60.1
FY23:
−62.1
FY24:
−42.1
FY25:
−57.0
Change from FY21 to FY25
millions USD
FY21:
−1.82
FY22:
−17.0
FY23:
3.08
FY24:
−3.39
FY25:
−0.31
Change from FY21 to FY25
millions USD
FY21:
121
FY22:
59.5
FY23:
20.9
FY24:
64.9
FY25:
17.3
millions USD
FY21:
70.9
FY22:
−17.5
FY23:
−38.1
FY24:
19.4
FY25:
−39.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.9
FY22:
−64.5
FY23:
−72.5
FY24:
−45.5
FY25:
−57.1

All amounts in millions USD Data source:SEC EDGAR